T1	Participants 115 130	type 2 diabetes
T2	Participants 212 232	diabetic nephropathy
T3	Participants 652 807	Forty patients who had diabetes with nephropathy and arteriosclerosis obliterans and had already been treated with angiotensin II receptor blocker (n = 40)
T4	Participants 1773 1793	diabetic nephropathy
